Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Omicron BA.2: What we know about the Covid sub-variant

Omicron BA.2: What we know about the Covid sub-variant

The highly transmissible Omicron variant now accounts for half of the world's infections.

But Omicron is an umbrella term for several closely related lineages of the SARS-CoV-2 coronavirus, the most common of which is the BA.1 lineage.

Now more countries, particularly in Asia and Europe, are reporting an increase in cases driven by BA.2.

While BA.2 appears to be more transmissible than previous variants, there is no data yet to suggest that it is any more severe.

So how worried should we be about this emerging variant? Here is what we know about it.

What is BA.2?


As viruses mutate into new variants, they sometimes split or branch off into sub-lineages. The Delta variant, for example, comprises 200 different sub-variants.

The same happened with Omicron, which includes the lineages BA.1, BA.2, BA.3 and B.1.1.529.

BA.1 accounts for most of the cases. According to the World Health Organization (WHO), nearly 99% of viral DNA submitted to the global GISAID database as of 25 January were identified as this sub-variant.

BA.2 was first detected in the Philippines


While BA.1 and BA.2 are similar, they are 20 mutations apart.

It is not clear where BA.2 originated, but it was first detected in the Philippines in November.

Where is BA.2 spreading?


The sub-variant of Omicron has been detected in 57 countries now, the WHO says. In some countries, BA.2 accounts for more than half of sequenced Omicron cases, it adds.

In some places, growth in recorded cases of the sub-variant has been sharp.

According to Denmark's Statens Serum Institut (SSI), BA.2 infections rose to account for about half of the country's reported Covid cases in January.

India is another country where BA.2 is rapidly replacing the Delta and Omicron BA.1 variant, according to molecular biologist Bijaya Dhakal.

It is already the dominant variant in several states and likely drove the country's recent third wave of infections.


The Philippines' Department of Health (DOH) said the BA.2 sub-lineage was already prevalent in samples it received at the end of January.

And in England, more than 1,000 confirmed cases of BA.2 have been identified, according to the UK Health Security Agency (UKHSA). It has been designated a "variant under investigation" by British health authorities, meaning they are keeping a close watch on it, but are not overly concerned by it.

BA.2 infections in Germany are also growing faster than BA.1 and Delta, according to Dr Meera Chand, Covid-19 director at the UKHSA.

Is BA.2 more transmissible?


A study of 8,500 households and 18,000 individuals conducted by Denmark's SSI found that BA.2 was "substantially" more transmissible than BA.1.

The study also showed evidence to suggest that the BA.2 sub-variant is better able to evade vaccines.

About half on new cases in Denmark are caused by BA.2


However, vaccinated people are still less likely to get infected than unvaccinated individuals, and they are also less likely to pass it on.

A separate UK study also found higher transmissibility for BA.2 compared to BA.1.

But the preliminary assessment found no evidence that vaccines would be any less effective against symptomatic disease for either sub-variant.

Is BA.2 more dangerous?


There is no data to suggest that BA.2 leads to more severe disease than previous Omicron sub-variants.

"Looking at other countries where BA.2 is now overtaking, we're not seeing any higher bumps in hospitalisation than expected," the WHO's Dr Boris Pavlin says.

Francois Balloux, Professor of Computational Systems Biology and director of the UCL Genetics Institute, said that BA.1 and BA.2 "can be considered as two epidemiologically largely equivalent sub-lineages of Omicron".

As with previous variants, experts believe vaccines will continue to be highly effective against severe illness, hospitalisation, and death.

Dr Chand said: "So far, there is insufficient evidence to determine whether BA.2 causes more severe illness than Omicron BA.1.

"We must remain vigilant and take up vaccinations. We should all continue to test regularly with LFDs [lateral flow devices] and take a PCR [polymerase chain reaction] test if symptoms develop."


No cause for alarm at this stage


Scientists in the UK and abroad are closely monitoring BA.2, a sub-variant of Omicron.

At the moment there is much that is not yet clear.

It appears to have a growth advantage compared to the version of Omicron, BA.1, that has swept the globe. Analysis by the UKHSA suggests it could be substantial, although there is a risk of over-estimating growth advantage in the early stages.

What we know is that it is certainly growing as a proportion of overall cases in the UK.

Because of a quirk in how it shows up in test results, we can see the numbers of suspected BA.2 doubled in the week up to 24 January.

But at that point the sub-variant still appeared to account for less than one in 20 cases.

That contrasts to Denmark, where it has become dominant.

A preliminary assessment by UKHSA did not find a difference in vaccine effectiveness, although it said there was no data yet available on severity.

But it is worth noting that Denmark has seen similar trends in terms of hospital admissions and intensive care as the UK has, suggesting BA.2 does not mark a sea-change in severity.

And even if it does become the dominant version of Omicron, it may not actually alter the trajectory of the pandemic in countries that have seen a big wave of BA.1. That's because there could be cross-immunity - an infection with BA.1 could offer some protection against BA.2.

It is one for the scientists to watch, rather than for the public to be alarmed about at this stage.

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
U.S. Goods Imports Plunge Nearly 20% Amid Tariff Disruptions
Italy Faces Population Decline Amid Youth Emigration
Trump Accuses China of Violating Trade Agreement
OpenAI Faces Competition from Cheaper AI Rivals
Foreign Tax Provision in U.S. Budget Bill Alarms Investors
Russia Accuses Serbia of Supplying Arms to Ukraine
Gerry Adams Wins Libel Case Against BBC
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
EU Majority Demands Hungary Reverse Anti-LGBTQ+ Laws
Top Hotel Picks for 2025 Stays in Budapest Revealed
Iron Maiden Unveils 2025 Tour Setlist in Budapest
Chinese Film Week Opens in Budapest to Promote Cultural Exchange
Budapest Airport Launches Direct Flights to Shymkent
Von der Leyen Denies Urging EU Officials to Skip Budapest Pride
Alcaraz and Sinner Advance with Convincing Wins at Roland Garros
EU Ministers Lack Consensus on Sanctioning Hungary Over Rule of Law
EU Nations Urge Action Against Hungary's Pride Parade Ban
Putin's Helicopter Reportedly Targeted by Ukrainian Drones
U.S. Considers Withdrawing Troops from Europe
Russia Deploys Motorbike Squads in Ukraine Conflict
Critics Accuse European Court of Human Rights of Overreach
Spain Proposes 100% Tax on Non-EU Holiday Home Purchases
German Intelligence Labels AfD as Far-Right Extremist
Geert Wilders Threatens Dutch Coalition Over Migration Policy
Hungary Faces Multiple Challenges Amid EU Tensions and Political Shifts
Denmark Increases Retirement Age to 70, Setting a European Precedent
Any trade deal with US must be based on respect not threats', says EU commissioner
UK Leads in Remote Work Adoption, Averaging 1.8 Days a Week
Thirteen Killed in Russian Attacks Across Ukraine
High-Profile Incidents and Political Developments Dominate Global News
Netanyahu Accuses Western Leaders of 'Emboldening Hamas'
Ukraine and Russia Conduct Largest Prisoner Exchange of the War
×